Antibody-drug conjugates key to Pfizer’s Seagen acquisition Finances April 1, 2023 Love Worker Pfizer’s (NYSE:PFE) acquisition of Seagen (NASDAQ:SGEN), introduced in March, is predicted to enhance the pharma big’s present portfolio…
Manhattan BioSolutions, Inc. Signs Commercial Evaluation License Agreements with the National Institutes of Health (NIH) for Use of Monoclonal Antibodies in Novel Antibody-Drug Conjugate (ADC) Oncology Programs Markets July 20, 2022 NEW YORK, NY / ACCESSWIRE / July 20, 2022 / Manhattan BioSolutions, Inc. at this time introduced it has entered…
